• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Barriers and enablers to opioid deprescription: A qualitative study.阿片类药物减停的障碍与促进因素:一项定性研究。
PLoS One. 2025 Jan 7;20(1):e0316730. doi: 10.1371/journal.pone.0316730. eCollection 2025.
2
Exploring the facilitators and barriers in opioid deprescribing for non-cancer pain treatment experienced by general practitioners: A qualitative study.探讨全科医生在非癌性疼痛治疗中减少阿片类药物使用的促进因素和障碍:一项定性研究。
Eur J Pain. 2024 Aug;28(7):1101-1115. doi: 10.1002/ejp.2243. Epub 2024 Jan 30.
3
Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain.老年人和初级保健医生对使用、开处和停用阿片类药物治疗慢性疼痛的看法。
JAMA Netw Open. 2024 Mar 4;7(3):e241342. doi: 10.1001/jamanetworkopen.2024.1342.
4
Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: protocol for a qualitative evidence synthesis using the Theoretical Domains Framework.慢性非癌性疼痛阿片类镇痛药监测与减药的障碍及促进因素:运用理论领域框架进行定性证据综合分析的方案
BMJ Open. 2019 Nov 12;9(11):e034039. doi: 10.1136/bmjopen-2019-034039.
5
Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study.理解家庭医生开具阿片类药物处方的行为决定因素:一项定性研究。
BMC Fam Pract. 2019 May 10;20(1):59. doi: 10.1186/s12875-019-0947-2.
6
[Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].[贝鲁特法国主宫医院阿片类镇痛药的处方模式]
Encephale. 2016 Dec;42(6):511-516. doi: 10.1016/j.encep.2016.05.010. Epub 2016 Oct 21.
7
Drivers, Beliefs, and Barriers Surrounding Surgical Opioid Prescribing: A Qualitative Study of Surgeons' Opioid Prescribing Habits.外科阿片类药物处方相关的驱动因素、信念和障碍:一项关于外科医生阿片类药物处方习惯的定性研究。
J Surg Res. 2020 Mar;247:86-94. doi: 10.1016/j.jss.2019.10.039. Epub 2019 Nov 22.
8
Development and validation of a training course on proton pump inhibitor deprescription for general practitioners in a rural continuing medical education program: a pilot study.开发并验证质子泵抑制剂减量处方在农村继续医学教育项目中用于全科医生培训课程:一项试点研究。
BMC Med Educ. 2024 Oct 27;24(1):1221. doi: 10.1186/s12909-024-06215-2.
9
Chronic noncancer pain management in primary care: family medicine physicians' risk assessment of opioid misuse.基层医疗中的慢性非癌性疼痛管理:家庭医学医生对阿片类药物滥用的风险评估
Postgrad Med. 2015 Jan;127(1):22-6. doi: 10.1080/00325481.2015.993572. Epub 2014 Dec 25.
10
Opioid deprescribing: Qualitative perspectives from those with chronic non-cancer pain.阿片类药物减用:慢性非癌痛患者的定性观点。
Res Social Adm Pharm. 2022 Dec;18(12):4083-4091. doi: 10.1016/j.sapharm.2022.07.043. Epub 2022 Aug 5.

本文引用的文献

1
Development and testing of an opioid tapering self-management intervention for chronic pain: I-WOTCH.开发和测试一种用于慢性疼痛的阿片类药物逐渐减量自我管理干预措施:I-WOTCH。
BMJ Open. 2022 Mar 16;12(3):e053725. doi: 10.1136/bmjopen-2021-053725.
2
Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.监测和减少慢性非癌症疼痛阿片类镇痛药的障碍和促进因素:使用理论领域框架进行系统评价和定性证据综合。
BMJ Qual Saf. 2022 May;31(5):387-400. doi: 10.1136/bmjqs-2021-014186. Epub 2022 Jan 21.
3
A multicomponent intervention to improve adherence to opioid prescribing and monitoring guidelines in primary care.一项多组分干预措施,旨在提高初级保健中对阿片类药物处方和监测指南的依从性。
J Opioid Manag. 2019 Nov/Dec;15(6):445-453. doi: 10.5055/jom.2019.0535.
4
Family Physician Perceptions of Their Role in Managing the Opioid Crisis.家庭医生对其在管理阿片类药物危机中角色的认知。
Ann Fam Med. 2019 Jul;17(4):345-351. doi: 10.1370/afm.2413.
5
Chronic Opioid Prescribing in Primary Care: Factors and Perspectives.基层医疗中长期阿片类药物处方:影响因素与观点。
Ann Fam Med. 2019 May;17(3):200-206. doi: 10.1370/afm.2357.
6
Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study.理解家庭医生开具阿片类药物处方的行为决定因素:一项定性研究。
BMC Fam Pract. 2019 May 10;20(1):59. doi: 10.1186/s12875-019-0947-2.
7
Setting Expectations, Following Orders, Safety, and Standardization: Clinicians' Strategies to Guide Difficult Conversations About Opioid Prescribing.设定期望、遵从医嘱、确保安全和标准化:临床医生指导关于阿片类药物处方的困难对话的策略。
J Gen Intern Med. 2019 Jul;34(7):1200-1206. doi: 10.1007/s11606-019-04983-y. Epub 2019 Apr 22.
8
Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic.模拟美国阿片类药物泛滥公共政策反应的健康效益和危害。
Am J Public Health. 2018 Oct;108(10):1394-1400. doi: 10.2105/AJPH.2018.304590. Epub 2018 Aug 23.
9
"Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications.“在我的经验中,这些对话进行得并不顺利”:一项关于初级保健提供者逐渐减少长期阿片类药物治疗经验的定性研究。
Pain Med. 2018 Nov 1;19(11):2201-2211. doi: 10.1093/pm/pnx276.
10
A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems.运用行为改变理论领域框架调查实施问题指南。
Implement Sci. 2017 Jun 21;12(1):77. doi: 10.1186/s13012-017-0605-9.

阿片类药物减停的障碍与促进因素:一项定性研究。

Barriers and enablers to opioid deprescription: A qualitative study.

作者信息

Lawrence Rebecca, Versteeg Everett, Pike Andrea, Etchegary Holly, Hall Amanda

机构信息

Primary Healthcare Research Unit, Memorial University, St. John's, Newfoundland and Labrador, Canada.

Pasqua Hospital, Regina, Saskatchewan, Canada.

出版信息

PLoS One. 2025 Jan 7;20(1):e0316730. doi: 10.1371/journal.pone.0316730. eCollection 2025.

DOI:10.1371/journal.pone.0316730
PMID:39774463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11706500/
Abstract

BACKGROUND

Canada has the fourth highest per capita rate of opioid prescriptions in the world, contributing to the country's opioid crisis. Due to both their pain-relieving and euphoric properties, opioids can be highly addictive, leading to potential overdose and death. Deprescription is an endorsed and organized method of discontinuing a drug but very little is known about the barriers that Canadian physicians face when attempting to deprescribe opioids, particularly those who practice in rural areas (which have some of the highest rates of opioid users).

METHODS

This was an explorative, qualitative study describing rural family doctors' experiences and practices regarding opioid deprescription in primary care. A convenience sample of family doctors who had experience working with patients taking opioid medications was recruited from the professional networks of study team members. After consenting to participate, data was collected using semi-structured telephone interviews and analyzed by researchers experienced in applying the Theoretical Domains Framework to assess barriers and enablers of behavior change.

PRINCIPAL FINDINGS

10 physicians participated in this study. Our analysis revealed four barriers and five enablers related to opioid deprescription in rural primary care. Barriers include a lack of knowledge and skills related to deprescribing, discomfort initiating deprescription, patient pressure to continue prescribing opioids, and a lack of foundational support required to deprescribe. Enablers include working with colleagues who share common views on overuse of opioids and deprescription; access to other healthcare providers, community-based resources, and clinical tools; using a systematic approach to deprescription; previous experience successfully deprescribing opioids; and practicing in a rural setting.

CONCLUSIONS

Opioid dependence and over-prescription continue to be a problem for our health system. Deprescription is necessary but challenging for family physicians. Rural physicians are keenly aware of the importance of preserving the physician-patient therapeutic relationship and open and clear communication about opioid medications and deprescription but feel unprepared to manage this in the face of difficult issues surrounding deprescription. They also feel unprepared to deal with deprescription effectively without access to other resources, healthcare professionals, patient education materials and time. Rural physicians would benefit most from added foundational supports for deprescription.

摘要

背景

加拿大的人均阿片类药物处方率在世界上排名第四,这加剧了该国的阿片类药物危机。由于阿片类药物具有止痛和欣快感特性,极易使人上瘾,从而可能导致过量用药和死亡。减药是一种被认可的、有组织的停药方法,但对于加拿大医生在尝试停用阿片类药物时所面临的障碍,尤其是在农村地区执业的医生(农村地区阿片类药物使用者比例较高),我们知之甚少。

方法

这是一项探索性的定性研究,描述了农村家庭医生在初级保健中进行阿片类药物减药的经验和做法。从研究团队成员的专业网络中招募了有与服用阿片类药物患者合作经验的家庭医生作为便利样本。在同意参与后,通过半结构化电话访谈收集数据,并由有应用理论领域框架评估行为改变障碍和促进因素经验的研究人员进行分析。

主要发现

10名医生参与了本研究。我们的分析揭示了农村初级保健中与阿片类药物减药相关的四个障碍和五个促进因素。障碍包括缺乏与减药相关的知识和技能、开始减药时的不适感、患者要求继续开具阿片类药物的压力以及减药所需的基础支持不足。促进因素包括与对阿片类药物过度使用和减药有共同看法的同事合作;能够接触到其他医疗服务提供者、社区资源和临床工具;采用系统的减药方法;以前成功减用阿片类药物的经验;以及在农村环境中执业。

结论

阿片类药物依赖和过度处方仍然是我们卫生系统面临的一个问题。减药对于家庭医生来说是必要的,但具有挑战性。农村医生敏锐地意识到维护医患治疗关系以及就阿片类药物和减药进行开放、清晰沟通的重要性,但面对减药过程中出现的棘手问题时,他们觉得没有准备好应对。他们还觉得,如果无法获得其他资源、医疗专业人员、患者教育材料和时间,就无法有效地处理减药问题。农村医生将从增加的减药基础支持中受益最大。